fda position on bpc-157 peptide FDA's Overreach Compounded Peptides FDA to review 7 popular

Currently, the BPC-157 peptide is not FDA-approved, and research is ongoing regarding its medical applications

After thorough examination, depending on the diagnosis, treatment may include topical minoxidil, low-dose oral minoxidil, correction of nutritional deficiencies, anti-androgen therapy in some women, platelet-rich plasma, treatment of dandruff or scalp inflammation, or clinical monitoring when the pattern is self-limiting

Because needs vary, we recommend discussing NAD+, B12, and IV therapy with a qualified clinician before adding new supplements or injection support to your routine

Tesamorelin FDA-approved for HIV-associated lipodystrophy, its used off-label to reduce abdominal fat and improve metabolic health